Literature DB >> 15747766

The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards.

Mary Gilbert Lawrence1.   

Abstract

PURPOSE: To evaluate the accuracy of two digital-video retinal imaging (DVRI) systems to detect diabetic retinopathy.
METHODS: A prospective, masked, technology assessment was conducted for two DVRI systems at a tertiary care Veterans Affairs Medical Center. Group A (n = 151 patients) was imaged with a 640x480 resolution system and group B (n = 103 patients) with an 800x600 resolution system. Four retinal evaluations were performed on each patient: DVRI with undilated pupils using one imaging field (U-DVRI), DVRI with dilated pupils using three imaging fields (D-DVRI), dilated clinical examination, and Early Treatment Diabetic Retinopathy Study stereoscopic seven-field photography (ETDRS-P). Two analyses of accuracy were conducted, one using ETDRS-P as a "gold standard" (ETDRS-GS) and one using dilated clinical examination as a "gold standard" (C-GS).
RESULTS: For group A, using the ETDRS-GS, sensitivities of U-DVRI and D-DVRI were 0.66 and 0.66; specificities of U-DVRI and D-DVRI were 0.66 and 0.86. Using the C-GS, sensitivities of U-DVRI and D-DVRI were 0.79 and 0.80; specificities of U-DVRI and D-DVRI were 0.68 and 0.85. For group B, using the ETDRS-GS, sensitivities of U-DVRI and D-DVRI were 0.76 and 0.85; specificities of U-DVRI and D-DVRI were 0.45 and 0.80. Using the C-GS, sensitivities of U-DVRI and D-DVRI were 0.81 and 0.87; specificities of U-DVRI and D-DVRI were 0.45 and 0.69. For both groups, dilation significantly improved specificities.
CONCLUSIONS: The 800x600 resolution DVRI system offers an accurate method of detecting diabetic retinopathy, provided there is adequate pupillary dilation and three retinal images are taken. DVRI technology may help facilitate retinal screenings of growing diabetic populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15747766      PMCID: PMC1280108     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  86 in total

1.  Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

Authors:  D J Propper; A C McDonald; A Man; P Thavasu; F Balkwill; J P Braybrooke; F Caponigro; P Graf; C Dutreix; R Blackie; S B Kaye; T S Ganesan; D C Talbot; A L Harris; C Twelves
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy.

Authors:  S E Bursell; J D Cavallerano; A A Cavallerano; A C Clermont; D Birkmire-Peters; L P Aiello; L M Aiello
Journal:  Ophthalmology       Date:  2001-03       Impact factor: 12.079

3.  Cost effectiveness analysis of screening for sight threatening diabetic eye disease.

Authors:  M James; D A Turner; D M Broadbent; J Vora; S P Harding
Journal:  BMJ       Date:  2000-06-17

4.  Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).

Authors:  E M Kohner ; I M Stratton; S J Aldington; R R Holman; D R Matthews
Journal:  Diabet Med       Date:  2001-03       Impact factor: 4.359

Review 5.  Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

Authors:  A Hutchinson; A McIntosh; J Peters; C O'Keeffe; K Khunti; R Baker; A Booth
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

6.  A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy.

Authors:  J I Lim; L LaBree; T Nichols; I Cardenas
Journal:  Ophthalmology       Date:  2000-05       Impact factor: 12.079

7.  A telemedical approach to the screening of diabetic retinopathy: digital fundus photography.

Authors:  B Liesenfeld; E Kohner; W Piehlmeier; S Kluthe; S Aldington; M Porta; T Bek; M Obermaier; H Mayer; G Mann; R Holle; K D Hepp
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

8.  Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system.

Authors:  Stephen R Fransen; Thomas C Leonard-Martin; William J Feuer; P Lloyd Hildebrand
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

Review 9.  Perspectives on diabetic retinopathy.

Authors:  Lloyd M Aiello
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

10.  The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography.

Authors:  Danny Y Lin; Mark S Blumenkranz; Rosemary J Brothers; David M Grosvenor
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

View more
  10 in total

Review 1.  Retinal imaging and image analysis.

Authors:  Michael D Abràmoff; Mona K Garvin; Milan Sonka
Journal:  IEEE Rev Biomed Eng       Date:  2010

2.  Automated detection of diabetic retinopathy: barriers to translation into clinical practice.

Authors:  Michael D Abramoff; Meindert Niemeijer; Stephen R Russell
Journal:  Expert Rev Med Devices       Date:  2010-03       Impact factor: 3.166

Review 3.  Clinical Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  EyePACS: an adaptable telemedicine system for diabetic retinopathy screening.

Authors:  Jorge Cuadros; George Bresnick
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.

Authors:  April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen
Journal:  J Diabetes Complications       Date:  2015-12-09       Impact factor: 2.852

6.  Role of a mydriasis-free, full-field flicker ERG device in the detection of diabetic retinopathy.

Authors:  Mehmet Fatih Kağan Değirmenci; Sibel Demirel; Figen Batıoğlu; Emin Özmert
Journal:  Doc Ophthalmol       Date:  2018-10-17       Impact factor: 2.379

Review 7.  Smartphone Sensors for Health Monitoring and Diagnosis.

Authors:  Sumit Majumder; M Jamal Deen
Journal:  Sensors (Basel)       Date:  2019-05-09       Impact factor: 3.576

8.  Consistency and standardization of color in medical imaging: a consensus report.

Authors:  Aldo Badano; Craig Revie; Andrew Casertano; Wei-Chung Cheng; Phil Green; Tom Kimpe; Elizabeth Krupinski; Christye Sisson; Stein Skrøvseth; Darren Treanor; Paul Boynton; David Clunie; Michael J Flynn; Tatsuo Heki; Stephen Hewitt; Hiroyuki Homma; Andy Masia; Takashi Matsui; Balázs Nagy; Masahiro Nishibori; John Penczek; Thomas Schopf; Yukako Yagi; Hideto Yokoi
Journal:  J Digit Imaging       Date:  2015-02       Impact factor: 4.056

9.  Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device.

Authors:  Motonobu Fukuo; Mineo Kondo; Akira Hirose; Harumi Fukushima; Kengo Ikesugi; Masahiko Sugimoto; Kumiko Kato; Yasuko Uchigata; Shigehiko Kitano
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Cost-effectiveness and diagnostic accuracy of telemedicine in macular disease and diabetic retinopathy: A systematic review and meta-analysis.

Authors:  Waqas Ullah; Sana Khan Pathan; Ankur Panchal; Swapna Anandan; Kaiser Saleem; Yasar Sattar; Ejaz Ahmad; Maryam Mukhtar; Haq Nawaz
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.